Last reviewed · How we verify

NCT06020326

A Retrospective Cohort Study of HFRS

Status unknown Last updated 31 August 2023
What this trial tests

trial in HFRS in 500 participants. Status unknown.

Timeline
5 May 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorTongji Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment500
Start date5 May 2022
Primary completion31 December 2023
Estimated completion31 December 2023
Sites8 locations across China

Conditions studied

Sponsor

Tongji Hospital

Who can join

18 and older, any sex, with HFRS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this retrospective cohort study is to learn about the clinial characteristics of HFRS patients, explore the risk factors of the occurrence and death of HFRS, and build a risk prediction model for HFRS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tongji Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06020326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing